Benchmark Holdings PLC Notice of Q3 Results (0055J)
August 11 2023 - 2:00AM
UK Regulatory
TIDMBMK
RNS Number : 0055J
Benchmark Holdings PLC
11 August 2023
11 August 2023
Benchmark Holdings plc
("Benchmark", the "Company" or the "Group")
Notice of Q3 Results
Presentation for analysts and institutional investors
Equity Development webcast for retail investors
Benchmark Holdings plc (AIM: BMK, Euronext Growth Oslo: BMK),
the aquaculture biotechnology business, will announce its Q3
results for the three month period ended 30 June 2023, on Thursday
24(th) August 2023.
Presentation for analysts and institutional investors at 08.00
UK time (09.00 CET)
Trond Williksen, Chief Executive Officer and Septima Maguire,
Chief Financial Officer will host a presentation for analysts and
institutional investors on the day at 08.00 UK time (09.00
CET).
The presentation will be held in person at DNB's offices in Oslo
at Dronning Eufemias gate 30, 0191 Oslo, Norway. If you would like
to attend in person, please contact Henriette Christensen at
henriette.gjeldvik.christensen@dnb.no
A live webcast of the presentation will be available for
analysts and investors to join remotely at the following link:
https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20230824_14
Equity Development webcast for retail investors at 12.00 UK
time
Trond Williksen, Chief Executive Officer and Septima Maguire,
Chief Financial Officer will host a second webcast for retail
investors and wealth managers on the day at 12.00pm UK time. The
webcast is open to all existing and potential shareholders.
To register please visit:
https://www.equitydevelopment.co.uk/news-and-events/benchmark-q3results-presentation-24aug2023
Enquiries
For further information, please contact:
Benchmark Holdings plc benchmark@mhpgroup.com
Trond Williksen, CEO
Septima Maguire, CFO
Ivonne Cantu, Investor Relations
Numis (Broker and NOMAD) Tel: 020 7260 1000
Freddie Barnfield, Duncan Monteith
MHP Tel: 020 3128 8004
Katie Hunt, Reg Hoare benchmark@mhpgroup.com
About Benchmark
Benchmark is a market leading aquaculture biotechnology company.
Benchmark's mission is to drive sustainability in aquaculture by
delivering products and solutions in genetics, advanced nutrition
and health which improve yield, growth and animal health and
welfare.
Through a global footprint in 26 countries and a broad portfolio
of products and solutions, Benchmark addresses many of the major
aquaculture species - salmon, shrimp, sea bass and sea bream, and
tilapia - in all the major aquaculture regions around the world.
Find out more at www.benchmarkplc.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORGPUGARUPWPUU
(END) Dow Jones Newswires
August 11, 2023 02:00 ET (06:00 GMT)
Benchmark (LSE:BMK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Benchmark (LSE:BMK)
Historical Stock Chart
From Jul 2023 to Jul 2024